Acasti Pharma Inc. (ACST)

🇺🇸NASDAQ

3.03 -0.1 (-3.19%)

At close: Jul 15, 2024, 4:00 PM

Company Description

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.

Key Executives

NamePosition
Dr. R. Loch MacDonald M.D., Ph.D.Member of Scientific Advisory Board & Chief Medical Officer
Mr. Amresh Kumar Ph.D.Vice President of Program Management
Mr. Prashant KohliChief Executive Officer & Director
Ms. Carrie D'AndreaVice President of Clinical Operations
Mr. Robert J. DelAversano CPAPrincipal Financial & Accounting Officer

Acasti Pharma Inc.

Acasti Pharma Inc. logo.
CountryCA
IPO DateFebruary 07, 2012
IndustryBiotechnology
SectorHealthcare
Employees32
CEOMr. Prashant Kohli

Contact Details

Address:
3009 boulevard de la Concorde East
Laval, QC
CA
Phone:450 687 2262
Website:acastipharma.com